Want to join the conversation?
Before special items, $DGX expects full-year 2015 revenue to approximate $7.49Bil vs. previous guidance of $7.49-7.57Bil and adjusted diluted EPS excluding amortization to be $4.75-4.80. Adjusted cash provided by operations is expected to exceed $850MM, while CapEx will approximate $275MM vs. prior guidance of $300MM for the full-year 2015.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?